Phibro Animal (PAHC) gains 5.1% passive stake from Barclays PLC

Rhea-AI Filing Summary

Barclays PLC reported a passive ownership stake in Phibro Animal Health Corp-A common stock on a Schedule 13G. Barclays beneficially owns 1,042,888 shares, representing 5.10% of the class, with sole voting and sole dispositive power over all reported shares as of December 31, 2025.

Barclays states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Phibro Animal Health. Subsidiaries involved include Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 11:06 AM Learn about SEC filing dates

FAQ

What did Barclays PLC disclose about Phibro Animal Health (PAHC)?

Barclays PLC disclosed a passive ownership position in Phibro Animal Health Corp-A common stock. It filed a Schedule 13G stating beneficial ownership of shares acquired and held in the ordinary course of business, without the purpose or effect of changing or influencing control of the company.

How many PAHC shares does Barclays PLC beneficially own?

Barclays PLC beneficially owns 1,042,888 shares of Phibro Animal Health Corp-A common stock. It reports sole voting power and sole dispositive power over the same 1,042,888 shares, indicating full authority to vote and dispose of this specific block of securities.

What percentage of Phibro Animal Health’s stock does Barclays hold?

Barclays PLC holds 5.10% of the outstanding common stock of Phibro Animal Health Corp-A. This percentage is based on its beneficial ownership of 1,042,888 shares, crossing the 5% threshold that requires public disclosure on a Schedule 13G filing.

Does Barclays intend to influence control of Phibro Animal Health (PAHC)?

Barclays states it does not intend to influence control of Phibro Animal Health. The filing certifies the securities were acquired and are held in the ordinary course of business, not for changing or influencing control or participating in transactions aimed at that purpose.

As of what date is Barclays’ ownership in PAHC reported?

Barclays’ ownership in Phibro Animal Health Corp-A is reported as of December 31, 2025. That date is the event requiring the Schedule 13G filing and anchors the disclosed 1,042,888 shares and 5.10% beneficial ownership percentage for regulatory reporting purposes.

Which Barclays entities are associated with the PAHC share ownership?

The filing identifies Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd as relevant subsidiaries. Barclays PLC reports beneficial ownership at the parent level, while these subsidiaries are referenced in connection with acquiring the securities and holding them on behalf of the group.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PHIBRO ANIMAL HEALTH CORP-A

(Name of Issuer)

COMMON-STOCK

(Title of Class of Securities)

71742Q106

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 71742Q106

1

Names of Reporting Persons

Barclays PLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,042,888.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,042,888.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,042,888.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.10 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PHIBRO ANIMAL HEALTH CORP-A
(b)	Address of issuer's principal executive offices: Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Boulevard, Suite 21, NJ, 07666
Item 2.
(a)	Name of person filing: Barclays PLC
(b)	Address or principal business office or, if none, residence: 1 Churchill Place, London - E14 5HP
(c)	Citizenship: X0
(d)	Title of class of securities: COMMON-STOCK
(e)	CUSIP No.: 71742Q106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1042888
(b)	Percent of class: 5.10 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1042888
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1042888
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Barclays PLC

Signature:	Ramya Rao
Name/Title:	Director
Date:	02/11/2026